Inventor
CARTER DARRICK
US54 patents
⚠️ This page may combine multiple inventors who share the name “CARTER DARRICK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CORIXA CORP
17 patentsUS6800746B2Oct 5, 2004
Compositions and methods for the therapy and diagnosis of prostate cancer
CORIXA CORP69 citations96
US6504010B1Jan 7, 2003
Compositions and methods for the therapy and diagnosis of lung cancer
CORIXA CORP59 citations96
US6943236B2Sep 13, 2005
Compositions and methods for the therapy and diagnosis of prostate cancer
CORIXA CORP21 citations92
US6746846B1Jun 8, 2004
Methods for diagnosing lung cancer
CORIXA CORP25 citations92
US6630305B1Oct 7, 2003
Compositions and methods for the therapy and diagnosis of prostate cancer
CORIXA CORP23 citations92
US6620922B1Sep 16, 2003
Compositions and methods for the therapy and diagnosis of prostate cancer
CORIXA CORP27 citations92
US6509448B2Jan 21, 2003
Compositions and methods for the therapy and diagnosis of lung cancer
CORIXA CORP32 citations92
US6858204B2Feb 22, 2005
Compositions and methods for the therapy and diagnosis of lung cancer
CORIXA CORP35 citations91
US6818751B1Nov 16, 2004
Compositions and methods for the therapy and diagnosis of prostate cancer
CORIXA CORP16 citations84
US6759515B1Jul 6, 2004
Compositions and methods for the therapy and diagnosis of prostate cancer
CORIXA CORP14 citations84
US6699664B1Mar 2, 2004
Compositions and methods for the therapy and diagnosis of ovarian cancer
CORIXA CORP16 citations84
US6630574B1Oct 7, 2003
Compositions and methods for the therapy and diagnosis of lung cancer
CORIXA CORP13 citations84
US7517952B1Apr 14, 2009
Compositions and methods for the therapy and diagnosis of prostate cancer
CORIXA CORP7 citations74
US7033827B2Apr 25, 2006
Prostate-specific polynucleotide compositions
CORIXA CORP7 citations73
US7425607B2Sep 16, 2008
Compositions comprising a lung tumor antigen
CORIXA CORP8 citations72
US7202342B1Apr 10, 2007
Compositions and methods for the therapy and diagnosis of prostate cancer
CORIXA CORP3 citations63
US6894146B1May 17, 2005
Compositions and methods for the therapy and diagnosis of prostate cancer
CORIXA CORP4 citations63
HDT BIO CORP
14 patentsUS11318213B2May 3, 2022
Compositions and methods for delivery of RNA
HDT BIO CORP20 citations97
US11534497B2Dec 27, 2022
Compositions and methods for delivery of RNA
HDT BIO CORP16 citations93
US11458209B2Oct 4, 2022
Compositions and methods for delivery of nucleic acid-lipid nanoparticle complexes encoding for viral RNA polymerase region and protein antigen
HDT BIO CORP16 citations93
US11433142B2Sep 6, 2022
Compositions and methods for delivery of RNA-lipid nanoparticle complexes encoding for viral RNA polymerase region and protein antigen
HDT BIO CORP15 citations93
US11376335B2Jul 5, 2022
RNA-lipid nanoparticle complexes of viral RNA polymerase region and SARS-CoV-2 spike protein region
HDT BIO CORP17 citations93
US11752218B2Sep 12, 2023
Nucleic acid-small diameter and liquid core nanoparticle complexed compositions
HDT BIO CORP3 citations83
US11654200B2May 23, 2023
Compositions and methods for delivery of RNA
HDT BIO CORP3 citations83
US11648322B2May 16, 2023
Compositions and methods for delivery of RNA
HDT BIO CORP3 citations83
US11648321B2May 16, 2023
Compositions and methods for delivery of RNA
HDT BIO CORP2 citations83
US12433957B2Oct 7, 2025
Compositions and methods for delivery of RNA
HDT BIO CORP0 citations72
US11896677B2Feb 13, 2024
Compositions and methods for delivery of RNA
HDT BIO CORP1 citations72
US11679163B2Jun 20, 2023
Compositions and methods for delivery of RNA
HDT BIO CORP2 citations72
US11559584B2Jan 24, 2023
Compositions and methods for delivery of RNA
HDT BIO CORP0 citations72
US12133894B2Nov 5, 2024
Compositions and methods for delivery of RNA
HDT BIO CORP0 citations62
INFECTIOUS DISEASE RES INST
10 patentsUS9907845B2Mar 6, 2018
Methods of using a vaccine composition containing synthetic adjuvant
INFECTIOUS DISEASE RES INST17 citations94
US9480740B2Nov 1, 2016
Synthetic glucopyranosyl lipid adjuvants
INFECTIOUS DISEASE RES INST28 citations94
US9987355B2Jun 5, 2018
Vaccine composition containing synthetic adjuvant
INFECTIOUS DISEASE RES INST13 citations93
US9950063B2Apr 24, 2018
Vaccine composition containing synthetic adjuvant
INFECTIOUS DISEASE RES INST16 citations93
US8343512B2Jan 1, 2013
Treatment of allergic conditions using a composition containing synthetic adjuvant
INFECTIOUS DISEASE RES INST30 citations93
US10632191B2Apr 28, 2020
Synthetic glucopyranosyl lipid adjuvants
INFECTIOUS DISEASE RES INST6 citations84
US9814772B2Nov 14, 2017
Synthetic glucopyranosyl lipid adjuvants
INFECTIOUS DISEASE RES INST5 citations84
US10792359B2Oct 6, 2020
Methods of using a vaccine composition containing synthetic adjuvant
INFECTIOUS DISEASE RES INST1 citations73
US10765736B2Sep 8, 2020
Vaccine composition containing synthetic adjuvant
INFECTIOUS DISEASE RES INST1 citations73
US11266602B2Mar 8, 2022
PEGylated liposomes and methods of use
INFECTIOUS DISEASE RES INST2 citations67
REED STEVEN G
4 patentsUS8722064B2May 13, 2014
Synthetic glucopyranosyl lipid adjuvants
REED STEVEN G46 citations98
US8273361B2Sep 25, 2012
Vaccine composition containing synthetic adjuvant
REED STEVEN G40 citations98
US8840908B2Sep 23, 2014
Vaccine composition containing synthetic adjuvant
REED STEVEN G25 citations96
US8609114B2Dec 17, 2013
Methods of using a vaccine composition containing synthetic adjuvant
REED STEVEN G28 citations96
TTI ELLEBEAU INC
2 patentsACCESS TO ADVANCED HEALTH INST
2 patentsCARTER DARRICK
1 patentShowing the top 50 of 54 patents by PatentIndex Score.